BPG is committed to discovery and dissemination of knowledge
Featured Articles
6/6/2025 6:59:32 AM | Browse: 321 | Download: 743
Publication Name World Journal of Gastroenterology
Manuscript ID 103184
Country China
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Letter to the Editor
Article Title Mechanisms underlying hepatocellular carcinoma progression through N6-methyladenosine modifications of long non-coding RNA
Manuscript Source Invited Manuscript
All Author List Ning Wang, Fei-Tian Min, Wei-Bo Wen and Huan-Tian Cui
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 82405223
Yunling Scholars Program XDYC-YLXZ-2022-0027
Corresponding Author Huan-Tian Cui, PhD, The First School of Clinical Medicine, Yunnan university of Chinese Medicine, No. 1076 Yuhua Road, Chenggong District, Kunming 650000, Yunnan Province, China. 1762316411@qq.com
Key Words Hepatocellular carcinoma; Stemness; Sorafenib resistance; Long non-coding RNA KIF9-AS1; Short stature homeobox 2; N6-methyladenosine
Core Tip Yu et al present evidence showing that m6A-modified long non-coding RNA KIF9-AS1 drives the progression of hepatocellular carcinoma (HCC) and reveal novel molecular mechanisms underlying this process. The m6A modification, mediated by modification involves methyltransferase-like 3 and insulin-like growth factor insulin-like growth factor 2 mRNA-binding protein 1, stabilizes and upregulates KIF9-AS1 expression. In turn, KIF9-AS1 enhances the stability and expression of SHOX2 by promoting its deubiquitination via ubiquitin-specific peptidase 1, which strengthens stemness and contributes to sorafenib resistance in HCC cells. Future studies should further validate KIF9-AS1 as a potential diagnostic biomarker for HCC and explore its therapeutic applications in HCC treatment.
Publish Date 2025-06-06 03:09
Citation

Wang N, Min FT, Wen WB, Cui HT. Mechanisms underlying hepatocellular carcinoma progression through N6-methyladenosine modifications of long non-coding RNA. World J Gastroenterol 2025; 31(21): 103184

URL https://www.wjgnet.com/1007-9327/full/v31/i21/103184.htm
DOI https://dx.doi.org/10.3748/wjg.v31.i21.103184
Full Article (PDF) WJG-31-103184-with-cover.pdf